Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin
Clinical trial NCT03608358 · TERMINATED
Trial details
- NCT number
- NCT03608358
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-27
- Primary completion
- 2020-08-04
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.